Author

C. B. Fox

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 5

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:host-pathogen & immune response· 3 Research Focus:cell type annotation· 2 Assay:flow cytometry· 2 Organism:mouse· 2 Organism:non-human primate· 2 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

K. Wiehe· 3 shared M. A. Tomai· 3 shared A. D. Curtis· 2 shared A. Sanzone· 2 shared B. F. Haynes· 2 shared D. Montefiori· 2 shared D. Weissman· 2 shared H. Chen· 2 shared

Activity by Year

2021-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

K. Wiehe

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Mutation-Guided Vaccine Design: A Strategy for Developing Boosting Immunogens for HIV Broadly Neutralizing Antibody Induction

K. Wiehe, K. O. Saunders, V. Stalls, D. W. Cain, S. Venkatayogi, J. S. Martin Beem, M. Berry, T. Evangelous, R. Henderson, B. Hora, S.-M. Xia, C. Jiang, A. Newman, C. Bowman, X. Lu, , B. F. Haynes

The paper demonstrates a mutation-guided vaccine strategy that induces HIV broadly neutralizing antibodies in mice by selecting for rare B cell lineage mutations.

bioRxiv · Nov 11, 2022 · PreprintImmunology

A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability

E. A. Voigt, A. Gerhardt, D. Hanson, P. Battisti, S. Reed, J. Singh, R. Mohamath, M. F. Jennewein, J. Bakken, S. Beaver, C. Press, P. Soon-Shiong, C. J. Paddon, C. B. Fox, C. Casper

This paper develops a self-amplifying RNA vaccine against SARS-CoV-2 with room-temperature stability and strong immune responses in preclinical studies.

bioRxiv · Mar 22, 2022Immunology

Different adjuvanted pediatric HIV envelope vaccines induced distinct plasma antibody responses despite similar B cell receptor repertoires in infant rhesus macaques.

G. G. Fouda, S. J. Berendam, P. K. Morgan-Asiedu, R. J. Mangan, S. Li, H. Heimsath, K. Luo, A. D. Curtis, J. A. Eudailey, C. B. Fox, M. A. Tomai, B. Phillips, H. L. Itell, E. Kunz, M. Hudgens, , M. A. Moody

bioRxiv · Aug 18, 2021Immunology

SARS-CoV-2 Vaccines Elicit Durable Immune Responses in Infant Rhesus Macaques

C. G. Garrado, A. D. Curtis, M. Dennis, S. H. Pathak, H. Gao, D. Montefiori, M. Tomai, C. B. Fox, P. A. Kozlowski, T. Scobey, J. E. Munt, M. L. Mallory, P. T. Saha, M. G. Hudgens, L. C. Lindesmith, , S. R. Permar

This study evaluates two SARS-CoV-2 vaccines in infant rhesus macaques, finding both induce durable antibody and T cell responses without adverse effects.

bioRxiv · Apr 5, 2021Immunology

SARS-CoV-2 vaccination induces neutralizing antibodies against pandemic and pre-emergent SARS-related coronaviruses in monkeys

K. O. Saunders, E. Lee, R. Parks, D. R. Martinez, D. Li, H. Chen, R. J. Edwards, S. M. C. Gobeil, M. Barr, K. Mansouri, S. M. Alam, L. L. Sutherland, F. Cai, A. Sanzone, M. Berry, , B. F. Haynes

This study shows that SARS-CoV-2 vaccines induce neutralizing antibodies against SARS-CoV-1, SARS-CoV-2, and batCoVs in monkeys.

bioRxiv · Feb 17, 2021 · PreprintImmunology